OCUL logo

Ocular Therapeutix, Inc. (OCUL) Cash From Operations

Annual CFO:

-$134.68M-$64.44M(-91.75%)
December 31, 2024

Summary

  • As of today, OCUL annual cash from operations is -$134.68 million, with the most recent change of -$64.44 million (-91.75%) on December 31, 2024.
  • During the last 3 years, OCUL annual cash from operations has fallen by -$69.13 million (-105.46%).
  • OCUL annual cash from operations is now -970.14% below its all-time high of -$12.59 million, reached on December 31, 2012.

Performance

OCUL Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherOCULcash flow metrics

Quarterly CFO:

-$50.73M+$4.51M(+8.17%)
September 30, 2025

Summary

  • As of today, OCUL quarterly cash from operations is -$50.73 million, with the most recent change of +$4.51 million (+8.17%) on September 30, 2025.
  • Over the past year, OCUL quarterly cash from operations has dropped by -$14.17 million (-38.75%).
  • OCUL quarterly cash from operations is now -1613.10% below its all-time high of -$2.96 million, reached on June 30, 2013.

Performance

OCUL Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherOCULcash flow metrics

TTM CFO:

-$190.06M-$14.17M(-8.05%)
September 30, 2025

Summary

  • As of today, OCUL TTM cash from operations is -$190.06 million, with the most recent change of -$14.17 million (-8.05%) on September 30, 2025.
  • Over the past year, OCUL TTM cash from operations has dropped by -$77.55 million (-68.92%).
  • OCUL TTM cash from operations is now -5528.16% below its all-time high of -$3.38 million, reached on March 31, 2013.

Performance

OCUL TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherOCULcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

OCUL Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-91.8%-38.8%-68.9%
3Y3 Years-105.5%-285.2%-228.8%
5Y5 Years-73.6%-271.4%-182.1%

OCUL Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-126.0%at low-292.7%+8.2%-228.8%at low
5Y5-Year-151.5%at low-712.1%+8.2%-265.1%at low
All-TimeAll-Time-970.1%at low-1613.1%+8.2%-5528.2%at low

OCUL Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$50.73M(+8.2%)
-$190.06M(-8.1%)
Jun 2025
-
-$55.24M(-23.7%)
-$175.90M(-20.9%)
Mar 2025
-
-$44.67M(-13.3%)
-$145.46M(-8.0%)
Dec 2024
-$134.68M(-91.8%)
-$39.43M(-7.9%)
-$134.68M(-19.7%)
Sep 2024
-
-$36.56M(-47.4%)
-$112.52M(-26.6%)
Jun 2024
-
-$24.80M(+26.8%)
-$88.88M(-5.6%)
Mar 2024
-
-$33.89M(-96.2%)
-$84.15M(-19.8%)
Dec 2023
-$70.23M(-17.8%)
-$17.27M(-33.7%)
-$70.23M(-0.4%)
Sep 2023
-
-$12.92M(+35.7%)
-$69.92M(+0.4%)
Jun 2023
-
-$20.07M(-0.5%)
-$70.17M(-15.1%)
Mar 2023
-
-$19.97M(-17.8%)
-$60.98M(-2.3%)
Dec 2022
-$59.60M(+9.1%)
-$16.96M(-28.8%)
-$59.60M(-3.1%)
Sep 2022
-
-$13.17M(-21.1%)
-$57.80M(-0.3%)
Jun 2022
-
-$10.88M(+41.5%)
-$57.61M(+13.7%)
Mar 2022
-
-$18.60M(-22.7%)
-$66.79M(-1.9%)
Dec 2021
-$65.55M(-22.4%)
-$15.15M(-16.7%)
-$65.55M(-15.7%)
Sep 2021
-
-$12.98M(+35.3%)
-$56.64M(+1.2%)
Jun 2021
-
-$20.06M(-15.5%)
-$57.32M(-10.1%)
Mar 2021
-
-$17.36M(-177.9%)
-$52.06M(+2.8%)
Dec 2020
-$53.55M(+31.0%)
-$6.25M(+54.3%)
-$53.55M(+20.5%)
Sep 2020
-
-$13.66M(+7.7%)
-$67.37M(+7.3%)
Jun 2020
-
-$14.80M(+21.5%)
-$72.66M(+5.7%)
Mar 2020
-
-$18.85M(+6.0%)
-$77.05M(+0.7%)
Dec 2019
-$77.58M
-$20.06M(-5.9%)
-$77.58M(-9.0%)
Sep 2019
-
-$18.95M(+1.2%)
-$71.16M(-12.8%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$19.18M(+1.1%)
-$63.09M(-12.4%)
Mar 2019
-
-$19.39M(-42.0%)
-$56.14M(-14.0%)
Dec 2018
-$49.23M(+2.5%)
-$13.65M(-25.5%)
-$49.23M(-7.1%)
Sep 2018
-
-$10.87M(+11.1%)
-$45.96M(+7.1%)
Jun 2018
-
-$12.23M(+1.9%)
-$49.47M(-2.3%)
Mar 2018
-
-$12.47M(-20.1%)
-$48.37M(+4.2%)
Dec 2017
-$50.47M(-48.4%)
-$10.38M(+27.8%)
-$50.47M(-5.8%)
Sep 2017
-
-$14.38M(-29.2%)
-$47.70M(-17.3%)
Jun 2017
-
-$11.13M(+23.6%)
-$40.65M(-3.4%)
Mar 2017
-
-$14.58M(-91.5%)
-$39.32M(-15.6%)
Dec 2016
-$34.00M(-0.8%)
-$7.61M(-3.8%)
-$34.00M(+2.9%)
Sep 2016
-
-$7.33M(+25.2%)
-$35.02M(+6.3%)
Jun 2016
-
-$9.80M(-5.9%)
-$37.39M(-3.5%)
Mar 2016
-
-$9.26M(-7.2%)
-$36.12M(-7.0%)
Dec 2015
-$33.74M(-64.6%)
-$8.64M(+11.0%)
-$33.74M(-9.8%)
Sep 2015
-
-$9.70M(-13.7%)
-$30.73M(-12.3%)
Jun 2015
-
-$8.53M(-24.0%)
-$27.37M(-17.2%)
Mar 2015
-
-$6.88M(-22.3%)
-$23.35M(-13.9%)
Dec 2014
-$20.50M(-62.1%)
-$5.63M(+11.2%)
-$20.50M(-37.8%)
Sep 2014
-
-$6.33M(-40.4%)
-$14.87M(-74.2%)
Jun 2014
-
-$4.51M(-12.1%)
-$8.54M(-22.2%)
Mar 2014
-
-$4.03M(-35.9%)
-$6.99M(-10.2%)
Dec 2013
-$12.64M(-0.5%)
-
-
Jun 2013
-
-$2.96M(+12.3%)
-$6.34M(-87.7%)
Mar 2013
-
-$3.38M
-$3.38M
Dec 2012
-$12.59M
-
-

FAQ

  • What is Ocular Therapeutix, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Ocular Therapeutix, Inc.?
  • What is Ocular Therapeutix, Inc. annual cash from operations year-on-year change?
  • What is Ocular Therapeutix, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Ocular Therapeutix, Inc.?
  • What is Ocular Therapeutix, Inc. quarterly cash from operations year-on-year change?
  • What is Ocular Therapeutix, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Ocular Therapeutix, Inc.?
  • What is Ocular Therapeutix, Inc. TTM cash from operations year-on-year change?

What is Ocular Therapeutix, Inc. annual cash from operations?

The current annual cash from operations of OCUL is -$134.68M

What is the all-time high annual cash from operations for Ocular Therapeutix, Inc.?

Ocular Therapeutix, Inc. all-time high annual cash from operations is -$12.59M

What is Ocular Therapeutix, Inc. annual cash from operations year-on-year change?

Over the past year, OCUL annual cash from operations has changed by -$64.44M (-91.75%)

What is Ocular Therapeutix, Inc. quarterly cash from operations?

The current quarterly cash from operations of OCUL is -$50.73M

What is the all-time high quarterly cash from operations for Ocular Therapeutix, Inc.?

Ocular Therapeutix, Inc. all-time high quarterly cash from operations is -$2.96M

What is Ocular Therapeutix, Inc. quarterly cash from operations year-on-year change?

Over the past year, OCUL quarterly cash from operations has changed by -$14.17M (-38.75%)

What is Ocular Therapeutix, Inc. TTM cash from operations?

The current TTM cash from operations of OCUL is -$190.06M

What is the all-time high TTM cash from operations for Ocular Therapeutix, Inc.?

Ocular Therapeutix, Inc. all-time high TTM cash from operations is -$3.38M

What is Ocular Therapeutix, Inc. TTM cash from operations year-on-year change?

Over the past year, OCUL TTM cash from operations has changed by -$77.55M (-68.92%)
On this page